ARA-290 (Cibinetide) Peptide

Innate repair receptor (IRR) agonist peptide. 11-amino acid peptide derived from erythropoietin helix B surface.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUACR-ARA290
CAS Number1208243-50-8
Molecular Weight1260.52 g/mol
SequenceHBSP (11-amino acid)
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is ARA-290?

ARA-290 (Cibinetide) is a non-erythropoietic EPO-derived peptide that activates the Innate Repair Receptor. It provides tissue protection and anti-inflammatory effects without stimulating red blood cell production.

Frequently Asked Questions

How does ARA-290 differ from EPO?

ARA-290 activates the Innate Repair Receptor without erythropoiesis. EPO activates both pathways. ARA-290 provides tissue protection without polycythemia risk.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.